Jonathan Stuart Kaplan
Examiner (ID: 15168)
Most Active Art Unit | 2836 |
Art Unit(s) | 2107, 2104, 2836 |
Total Applications | 226 |
Issued Applications | 203 |
Pending Applications | 10 |
Abandoned Applications | 13 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7103835
[patent_doc_number] => 20050106561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Method for predicting the severity of viral hepatitis type B in patients treated with an anti-viral agent, and a kit for diagnosing viral hepatitis type B'
[patent_app_type] => utility
[patent_app_number] => 10/913910
[patent_app_country] => US
[patent_app_date] => 2004-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4219
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20050106561.pdf
[firstpage_image] =>[orig_patent_app_number] => 10913910
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/913910 | Method for predicting the severity of viral hepatitis type B in patients treated with an anti-viral agent, and a kit for diagnosing viral hepatitis type B | Aug 5, 2004 | Abandoned |
Array
(
[id] => 7116568
[patent_doc_number] => 20050069869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-31
[patent_title] => 'SARS nucleic acids, proteins, antibodies, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/911838
[patent_app_country] => US
[patent_app_date] => 2004-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 72
[patent_figures_cnt] => 72
[patent_no_of_words] => 29049
[patent_no_of_claims] => 82
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20050069869.pdf
[firstpage_image] =>[orig_patent_app_number] => 10911838
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/911838 | SARS nucleic acids, proteins, antibodies, and uses thereof | Aug 3, 2004 | Issued |
Array
(
[id] => 7185226
[patent_doc_number] => 20050191747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Recombinant bovine immunodeficiency virus based gene transfer system'
[patent_app_type] => utility
[patent_app_number] => 10/910293
[patent_app_country] => US
[patent_app_date] => 2004-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 26893
[patent_no_of_claims] => 99
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20050191747.pdf
[firstpage_image] =>[orig_patent_app_number] => 10910293
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/910293 | Recombinant bovine immunodeficiency virus based gene transfer system | Aug 3, 2004 | Abandoned |
Array
(
[id] => 7033131
[patent_doc_number] => 20050031640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma'
[patent_app_type] => utility
[patent_app_number] => 10/910596
[patent_app_country] => US
[patent_app_date] => 2004-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5229
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20050031640.pdf
[firstpage_image] =>[orig_patent_app_number] => 10910596
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/910596 | Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma | Aug 2, 2004 | Issued |
Array
(
[id] => 281944
[patent_doc_number] => 07553944
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-30
[patent_title] => 'Human virus causing respiratory tract infection and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/895064
[patent_app_country] => US
[patent_app_date] => 2004-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 119
[patent_figures_cnt] => 9
[patent_no_of_words] => 19390
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/553/07553944.pdf
[firstpage_image] =>[orig_patent_app_number] => 10895064
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/895064 | Human virus causing respiratory tract infection and uses thereof | Jul 20, 2004 | Issued |
Array
(
[id] => 6938991
[patent_doc_number] => 20050112554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Characterization of the earliest stages of the severe acute respiratory syndrome (SARS) virus and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/888401
[patent_app_country] => US
[patent_app_date] => 2004-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 21609
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112554.pdf
[firstpage_image] =>[orig_patent_app_number] => 10888401
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/888401 | Characterization of the earliest stages of the severe acute respiratory syndrome (SARS) virus and uses thereof | Jul 8, 2004 | Issued |
Array
(
[id] => 6938581
[patent_doc_number] => 20050112144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Hepatitis A vaccines'
[patent_app_type] => utility
[patent_app_number] => 10/878094
[patent_app_country] => US
[patent_app_date] => 2004-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4135
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112144.pdf
[firstpage_image] =>[orig_patent_app_number] => 10878094
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/878094 | Hepatitis A vaccines | Jun 27, 2004 | Abandoned |
Array
(
[id] => 5045973
[patent_doc_number] => 20070264646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'Hbv Particles Containing Hbv-Rna'
[patent_app_type] => utility
[patent_app_number] => 11/630254
[patent_app_country] => US
[patent_app_date] => 2004-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3275
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20070264646.pdf
[firstpage_image] =>[orig_patent_app_number] => 11630254
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/630254 | Hbv Particles Containing Hbv-Rna | Jun 21, 2004 | Abandoned |
Array
(
[id] => 7275103
[patent_doc_number] => 20040234554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'HBV core antigen particles with multiple immunogenic components attached via peptide ligands'
[patent_app_type] => new
[patent_app_number] => 10/872550
[patent_app_country] => US
[patent_app_date] => 2004-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10079
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20040234554.pdf
[firstpage_image] =>[orig_patent_app_number] => 10872550
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/872550 | HBV core antigen particles with multiple immunogenic components attached via peptide ligands | Jun 20, 2004 | Issued |
Array
(
[id] => 7275091
[patent_doc_number] => 20040234542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Recombinant orf2 proteins of the swine hepatitis e virus and their use as a vaccine and as a diagnostic reagent for medical and veterinary applications'
[patent_app_type] => new
[patent_app_number] => 10/476777
[patent_app_country] => US
[patent_app_date] => 2004-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 9145
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20040234542.pdf
[firstpage_image] =>[orig_patent_app_number] => 10476777
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/476777 | Recombinant orf2 proteins of the swine hepatitis e virus and their use as a vaccine and as a diagnostic reagent for medical and veterinary applications | Jun 6, 2004 | Abandoned |
Array
(
[id] => 7152638
[patent_doc_number] => 20050025788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-03
[patent_title] => 'Systemic delivery of non-viral vector expressing SARS viral genomic vaccine'
[patent_app_type] => utility
[patent_app_number] => 10/860119
[patent_app_country] => US
[patent_app_date] => 2004-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6080
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20050025788.pdf
[firstpage_image] =>[orig_patent_app_number] => 10860119
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/860119 | Systemic delivery of non-viral vector expressing SARS viral genomic vaccine | Jun 3, 2004 | Abandoned |
Array
(
[id] => 7252581
[patent_doc_number] => 20040259243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Cells for detection of enteroviruses'
[patent_app_type] => new
[patent_app_number] => 10/861724
[patent_app_country] => US
[patent_app_date] => 2004-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18079
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20040259243.pdf
[firstpage_image] =>[orig_patent_app_number] => 10861724
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/861724 | Cells for detection of enteroviruses | Jun 2, 2004 | Issued |
Array
(
[id] => 7372152
[patent_doc_number] => 20040219171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'In ovo protection against infectious bronchitis'
[patent_app_type] => new
[patent_app_number] => 10/858277
[patent_app_country] => US
[patent_app_date] => 2004-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4820
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20040219171.pdf
[firstpage_image] =>[orig_patent_app_number] => 10858277
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/858277 | Ovo immunization against infectious bronchitis | May 31, 2004 | Issued |
Array
(
[id] => 6931244
[patent_doc_number] => 20050282279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Expression vector encoding coronavirus-like particle'
[patent_app_type] => utility
[patent_app_number] => 10/855490
[patent_app_country] => US
[patent_app_date] => 2004-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5539
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282279.pdf
[firstpage_image] =>[orig_patent_app_number] => 10855490
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/855490 | Expression vector encoding coronavirus-like particle | May 27, 2004 | Abandoned |
Array
(
[id] => 5732306
[patent_doc_number] => 20060257423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Intracutaneous injection combined vaccine included hevac and bcg for and preparation method'
[patent_app_type] => utility
[patent_app_number] => 10/559471
[patent_app_country] => US
[patent_app_date] => 2004-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3263
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257423.pdf
[firstpage_image] =>[orig_patent_app_number] => 10559471
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/559471 | HBsAg-BCG combined vaccine for intracutaneous injection and preparation method thereof | May 25, 2004 | Issued |
Array
(
[id] => 698337
[patent_doc_number] => 07067249
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-27
[patent_title] => 'Inhibition of hepatitis B virus (HBV) replication by RNA interference'
[patent_app_type] => utility
[patent_app_number] => 10/848736
[patent_app_country] => US
[patent_app_date] => 2004-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 11978
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/067/07067249.pdf
[firstpage_image] =>[orig_patent_app_number] => 10848736
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/848736 | Inhibition of hepatitis B virus (HBV) replication by RNA interference | May 18, 2004 | Issued |
Array
(
[id] => 7426656
[patent_doc_number] => 20040265798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Methods and compositions related to high-titer pseudotyped retroviruses'
[patent_app_type] => new
[patent_app_number] => 10/845253
[patent_app_country] => US
[patent_app_date] => 2004-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 23387
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20040265798.pdf
[firstpage_image] =>[orig_patent_app_number] => 10845253
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/845253 | Methods and compositions related to high-titer pseudotyped retroviruses | May 12, 2004 | Issued |
Array
(
[id] => 7689505
[patent_doc_number] => 20070105193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Severe acute respiratory syndrome DNA vaccine compositions and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/843656
[patent_app_country] => US
[patent_app_date] => 2004-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 70388
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20070105193.pdf
[firstpage_image] =>[orig_patent_app_number] => 10843656
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/843656 | Severe acute respiratory syndrome DNA compositions and methods of use | May 11, 2004 | Issued |
Array
(
[id] => 5040654
[patent_doc_number] => 20070092936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-26
[patent_title] => 'Severe acute respiratory syndrome'
[patent_app_type] => utility
[patent_app_number] => 10/553844
[patent_app_country] => US
[patent_app_date] => 2004-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 2922
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20070092936.pdf
[firstpage_image] =>[orig_patent_app_number] => 10553844
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/553844 | Severe acute respiratory syndrome | May 9, 2004 | Abandoned |
Array
(
[id] => 7421643
[patent_doc_number] => 20040229219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Method of inhibiting human metapneumovirus and human coronavirus in the prevention and treatment of severe acute respiratory syndrome (SARS)'
[patent_app_type] => new
[patent_app_number] => 10/834666
[patent_app_country] => US
[patent_app_date] => 2004-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 21416
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20040229219.pdf
[firstpage_image] =>[orig_patent_app_number] => 10834666
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/834666 | Method of inhibiting human metapneumovirus and human coronavirus in the prevention and treatment of severe acute respiratory syndrome (SARS) | Apr 28, 2004 | Abandoned |